Slow Release Drug Implant Study - LUCIDA Clinical Trial

The Lucida Clinical Trial is evaluating the use of an investigational implant to see if it may prevent the transplanted cornea from being rejected by the body's immune system.  The study drug is implanted in the eye during a simple procedure.  The investigational implant is made of silicone and releases a medication called cyclosporine A.  Cyclosporine A is a drug that is commonly used to help prevent the rejection of transplanted organs by the body; however, its use in this study is investigational.

If you, or someone you know, have experienced a corneal graft rejection episode within the past 6 months and are at least 18 years of age, you may be eligible to participate in the LUCIDA Clinical Trial.  Participants will receive study-related care and investigational therapy at no cost for the duration of the trial.

If you are interested in learning more about the LUCIDA Clinical Trial, please call Clorissa Quillin of the Cornea Research Foundation at 317- 814-2996.